Cargando…
Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis
OBJECTIVE: Semaphorin 3B (Sema3B) decreases the migratory and invasive capacities of fibroblast‐like synoviocytes (FLS) in rheumatoid arthritis (RA) and suppresses expression of matrix metalloproteinases. We undertook this study to examine the role of Sema3B in a mouse model of arthritis and its exp...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322571/ https://www.ncbi.nlm.nih.gov/pubmed/35001548 http://dx.doi.org/10.1002/art.42065 |
_version_ | 1784756337728552960 |
---|---|
author | Igea, Ana Carvalheiro, Tiago Malvar‐Fernández, Beatriz Martinez‐Ramos, Sara Rafael‐Vidal, Carlos Niemantsverdriet, Ellis Varadé, Jezabel Fernández‐Carrera, Andrea Jimenez, Norman McGarry, Trudy Rodriguez‐Trillo, Angela Veale, Douglas Fearon, Ursula Conde, Carmen Pego‐Reigosa, Jose M. González‐Fernández, África Reedquist, Kris A. Radstake, Timothy R. D. J. van der Helm‐Van Mil, Annette García, Samuel |
author_facet | Igea, Ana Carvalheiro, Tiago Malvar‐Fernández, Beatriz Martinez‐Ramos, Sara Rafael‐Vidal, Carlos Niemantsverdriet, Ellis Varadé, Jezabel Fernández‐Carrera, Andrea Jimenez, Norman McGarry, Trudy Rodriguez‐Trillo, Angela Veale, Douglas Fearon, Ursula Conde, Carmen Pego‐Reigosa, Jose M. González‐Fernández, África Reedquist, Kris A. Radstake, Timothy R. D. J. van der Helm‐Van Mil, Annette García, Samuel |
author_sort | Igea, Ana |
collection | PubMed |
description | OBJECTIVE: Semaphorin 3B (Sema3B) decreases the migratory and invasive capacities of fibroblast‐like synoviocytes (FLS) in rheumatoid arthritis (RA) and suppresses expression of matrix metalloproteinases. We undertook this study to examine the role of Sema3B in a mouse model of arthritis and its expression in RA patients. METHODS: Clinical responses, histologic features, and FLS function were examined in wild‐type (WT) and Sema3B(−/−) mice in a K/BxN serum transfer model of arthritis. Protein and messenger RNA expression of Sema3B in mouse joints and murine FLS, as well as in serum and synovial tissue from patients with arthralgia and patients with RA, was determined using enzyme‐linked immunosorbent assay, immunoblotting, quantitative polymerase chain reaction, and RNA sequencing. FLS migration was determined using a wound closure assay. RESULTS: The clinical severity of serum‐induced arthritis was significantly higher in Sema3B(−/−) mice compared to WT mice. This was associated with increased expression of inflammatory mediators and increased migratory capacity of murine FLS. Administration of recombinant mouse Sema3B reduced the clinical severity of serum‐induced arthritis and the expression of inflammatory mediators. Sema3B expression was significantly lower in the synovial tissue and serum of patients with established RA compared to patients with arthralgia. Serum Sema3B levels were elevated in patients with arthralgia that later progressed to RA, but not in those who did not develop RA; however, these levels drastically decreased 1 and 2 years after RA development. CONCLUSION: Sema3B expression plays a protective role in a mouse model of arthritis. In RA patients, expression levels of Sema3B in the serum depend on the disease stage, suggesting different regulatory roles in disease onset and progression. |
format | Online Article Text |
id | pubmed-9322571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93225712022-07-30 Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis Igea, Ana Carvalheiro, Tiago Malvar‐Fernández, Beatriz Martinez‐Ramos, Sara Rafael‐Vidal, Carlos Niemantsverdriet, Ellis Varadé, Jezabel Fernández‐Carrera, Andrea Jimenez, Norman McGarry, Trudy Rodriguez‐Trillo, Angela Veale, Douglas Fearon, Ursula Conde, Carmen Pego‐Reigosa, Jose M. González‐Fernández, África Reedquist, Kris A. Radstake, Timothy R. D. J. van der Helm‐Van Mil, Annette García, Samuel Arthritis Rheumatol Rheumatoid Arthritis OBJECTIVE: Semaphorin 3B (Sema3B) decreases the migratory and invasive capacities of fibroblast‐like synoviocytes (FLS) in rheumatoid arthritis (RA) and suppresses expression of matrix metalloproteinases. We undertook this study to examine the role of Sema3B in a mouse model of arthritis and its expression in RA patients. METHODS: Clinical responses, histologic features, and FLS function were examined in wild‐type (WT) and Sema3B(−/−) mice in a K/BxN serum transfer model of arthritis. Protein and messenger RNA expression of Sema3B in mouse joints and murine FLS, as well as in serum and synovial tissue from patients with arthralgia and patients with RA, was determined using enzyme‐linked immunosorbent assay, immunoblotting, quantitative polymerase chain reaction, and RNA sequencing. FLS migration was determined using a wound closure assay. RESULTS: The clinical severity of serum‐induced arthritis was significantly higher in Sema3B(−/−) mice compared to WT mice. This was associated with increased expression of inflammatory mediators and increased migratory capacity of murine FLS. Administration of recombinant mouse Sema3B reduced the clinical severity of serum‐induced arthritis and the expression of inflammatory mediators. Sema3B expression was significantly lower in the synovial tissue and serum of patients with established RA compared to patients with arthralgia. Serum Sema3B levels were elevated in patients with arthralgia that later progressed to RA, but not in those who did not develop RA; however, these levels drastically decreased 1 and 2 years after RA development. CONCLUSION: Sema3B expression plays a protective role in a mouse model of arthritis. In RA patients, expression levels of Sema3B in the serum depend on the disease stage, suggesting different regulatory roles in disease onset and progression. Wiley Periodicals, Inc. 2022-04-13 2022-06 /pmc/articles/PMC9322571/ /pubmed/35001548 http://dx.doi.org/10.1002/art.42065 Text en © 2022 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Rheumatoid Arthritis Igea, Ana Carvalheiro, Tiago Malvar‐Fernández, Beatriz Martinez‐Ramos, Sara Rafael‐Vidal, Carlos Niemantsverdriet, Ellis Varadé, Jezabel Fernández‐Carrera, Andrea Jimenez, Norman McGarry, Trudy Rodriguez‐Trillo, Angela Veale, Douglas Fearon, Ursula Conde, Carmen Pego‐Reigosa, Jose M. González‐Fernández, África Reedquist, Kris A. Radstake, Timothy R. D. J. van der Helm‐Van Mil, Annette García, Samuel Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis |
title | Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis |
title_full | Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis |
title_fullStr | Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis |
title_full_unstemmed | Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis |
title_short | Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis |
title_sort | central role of semaphorin 3b in a serum‐induced arthritis model and reduced levels in patients with rheumatoid arthritis |
topic | Rheumatoid Arthritis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322571/ https://www.ncbi.nlm.nih.gov/pubmed/35001548 http://dx.doi.org/10.1002/art.42065 |
work_keys_str_mv | AT igeaana centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT carvalheirotiago centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT malvarfernandezbeatriz centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT martinezramossara centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT rafaelvidalcarlos centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT niemantsverdrietellis centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT varadejezabel centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT fernandezcarreraandrea centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT jimeneznorman centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT mcgarrytrudy centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT rodrigueztrilloangela centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT vealedouglas centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT fearonursula centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT condecarmen centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT pegoreigosajosem centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT gonzalezfernandezafrica centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT reedquistkrisa centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT radstaketimothyrdj centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT vanderhelmvanmilannette centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis AT garciasamuel centralroleofsemaphorin3binaseruminducedarthritismodelandreducedlevelsinpatientswithrheumatoidarthritis |